Skip to main content

Acalabrutinib for Mantle Cell Lymphoma User Reviews

Brand names: Calquence

Acalabrutinib has an average rating of 7.5 out of 10 from a total of 4 reviews for the treatment of Mantle Cell Lymphoma. 75% of reviewers reported a positive experience, while 25% reported a negative experience.

Acalabrutinib rating summary

7.5/10 average rating

4 ratings from 4 user reviews.

Compare all 19 medications used in the treatment of Mantle Cell Lymphoma.

10
50%
9
0%
8
25%
7
0%
6
0%
5
0%
4
0%
3
0%
2
25%
1
0%
  • Frank
  • Taken for 1 to 6 months
  • October 15, 2023

Calquence (acalabrutinib) "My latest PET Scan showed that Calquence is working to reduce MCL activity. Side effects mostly occurred when I started the medication and they were brief. These included fatigue, tinnitus in my left ear, lower appetite and weight loss. My weight is now stable, although down about 13 pounds from when I started. But I’m ok with that, since it’s a better weight for me. I do have some rashes, which my oncologist says it’s due to the medication."

8 / 10
Was this helpful?YesNo
5 Report
  • Chester
  • Taken for 1 to 6 months
  • August 30, 2023

Calquence (acalabrutinib) "So far, no major issues. I have been using it for about 4 months now, since Imbruvica was pulled for mantle cell lymphoma treatment. Bowels move a bit differently than with Imbruvica, but not enough so as to be a problem. My doctors seem to be well satisfied with the way it is working, holding the lymphoma in check if nothing else."

10 / 10
Was this helpful?YesNo
5 Report
  • Tree...
  • Taken for 1 to 6 months
  • April 28, 2021

"Remission after Retuxen and Bendeka was only about 4-5 months at best so this was next after one failure. 1st month was fine- few side effects and obvious symptoms decreased but by the end of month 3 my symptoms returned. Side effects became distressing- GERD with fatty sensations, nightly abdominal pain … so disappointing. It seems odd for a mere patient to review a drug since medicine is hardly straight forward."

2 / 10
Was this helpful?YesNo
4 Report

Frequently asked questions

  • Nancy...
  • Taken for 1 to 6 months
  • May 14, 2024

Calquence (acalabrutinib) "Minor side effects very manageable. I highly recommend trying Calquence!"

10 / 10
Was this helpful?YesNo
0 Report

Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.